Incyte Announces EMA CHMP Positive Opinion Recommending Approval Of Opzelura Cream For Moderate Atopic Dermatitis; Application Now Referred To European Commission For Final Action

뉴스 본문을 불러오고 있어요.

Incyte Announces EMA CHMP Positive Opinion Recommending Approval Of Opzelura Cream For Moderate Atopic Dermatitis; Application Now Referred To European Commission For Final Action | 웨이프 WAPE

Incyte Announces EMA CHMP Positive Opinion Recommending Approval Of Opzelura Cream For Moderate Atopic Dermatitis; Application Now Referred To European Commission For Final Action

기사 요약

관련 종목

댓글 —